Valuation Abbott Laboratories (Pakistan) Limited

Stocks

End-of-day quote Pakistan S.E. 30/10/2026			5-day change	1st Jan Change
966.69 ^PKR	-0.52%		+4.21%	-7.95%

10-27	Abbott Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
08-28	Abbott Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2024	2025	2026	2027	2028
Market Cap ¹	121,187	102,809	94,639	-	-
Change	-	-15.16%	-7.95%	-	-
Enterprise Value (EV)	121,187	102,809	94,639	94,639	94,639
Change	-	-15.16%	-7.95%	0%	0%
P/E	23.2x	-	-	-	-
PBR	-	-	2.5x	2.08x	1.81x
PEG	-	-	-	-	-
Capitalization / Revenue	-	-	-	-	-
EV / Revenue	-	-	-	-	-
EV / EBITDA	-	-	-	-	-
EV / EBIT	-	-	-	-	-
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	40	50	64	67
Rate of return	-	3.81%	5.17%	6.62%	6.93%
EPS ²	53.46	-	-	-	-
Distribution rate	-	-	-	-	-
Net sales	-	-	-	-	-
EBITDA	-	-	-	-	-
EBIT	-	-	-	-	-
Net income	5,234	-	-	-	-
Net Debt	-	-	-	-	-
Reference price ²	1,237.86	1,050.14	966.69	966.69	966.69
Nbr of stocks (in thousands)	97,900	97,900	97,900	-	-
Announcement Date	20/02/25	16/03/26	-	-	-

¹PKR in Million²PKR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ABBOTT LABORATORIES (PAKISTAN) LIMITED	-	-	-	5.17%	342M
ELI LILLY AND COMPANY	41.42x	14.01x	31.06x	0.48%	1,263B
JOHNSON & JOHNSON	39.99x	6.71x	18.89x	1.95%	658B
ABBVIE INC.	36.71x	8.6x	17.71x	2.35%	521B
ROCHE HOLDING AG	21.74x	5.27x	13.12x	2.48%	391B
MERCK & CO., INC.	97.38x	6.07x	25.8x	2.28%	369B
NOVARTIS AG	23.19x	5.95x	14.36x	2.69%	307B
ASTRAZENECA PLC	24.47x	4.89x	13.87x	1.77%	290B
AMGEN INC.	29.55x	7.53x	13.48x	2.16%	252B
GILEAD SCIENCES, INC.	-40.86x	7.45x	46.76x	1.94%	212B
Average	30.40x	7.39x	21.67x	2.33%	426.23B
Weighted average by Cap.	36.41x	8.82x	22.82x	1.69%